WuXi AppTec is a trusted partner and contributor to the pharmaceutical and life sciences industries, providing R&D and manufacturing services that help advance healthcare innovation. With operations across Asia, Europe, and North America, we offer integrated, end-to-end services through our unique CRDMO (Contract Research, Development, and Manufacturing Organization) platform. We are privileged to work alongside partners across 30+ countries, supporting their efforts to bring breakthrough treatments to patients. Guided by our vision that every drug can be made and every disease can be treated, we are committed to advancing breakthroughs for patients—one collaboration at a time.
Shared 4 months ago
20 views
Shared 4 months ago
16 views
Shared 4 months ago
24 views
Shared 4 months ago
11 views
Shared 6 months ago
127 views
Shared 10 months ago
133 views
Shared 10 months ago
226 views
Shared 10 months ago
168 views
Shared 10 months ago
90 views
Shared 10 months ago
70 views
Shared 10 months ago
35 views
Shared 10 months ago
140 views
Shared 11 months ago
53 views
Shared 11 months ago
143 views
Shared 11 months ago
327 views
Shared 11 months ago
90 views
Shared 11 months ago
50 views
A Global Village for Global Impact: Talk with Michael Altorfer, CEO of the Swiss Biotech Association
Shared 11 months ago
62 views
Shared 11 months ago
58 views
Shared 3 years ago
33 views
Shared 3 years ago
112 views
Shared 3 years ago
49 views
Shared 3 years ago
57 views
Shared 3 years ago
13 views
Shared 3 years ago
34 views
Shared 3 years ago
12 views
Fragile X Syndrome: Innovative Approaches to Finding a Cure |Targeted Therapy (Christopher Missling)
Shared 3 years ago
192 views
Shared 3 years ago
10 views
Shared 3 years ago
58 views
Fragile X Syndrome: Innovative Approaches to Finding a Cure |Targeted Therapy Adrian Newman-Tancredi
Shared 3 years ago
12 views
Shared 3 years ago
41 views
Shared 3 years ago
48 views
Shared 3 years ago
25 views
Shared 3 years ago
8 views
Shared 3 years ago
13 views
Shared 3 years ago
13 views
Shared 3 years ago
8 views
Shared 3 years ago
34 views
Shared 3 years ago
61 views
Shared 3 years ago
6 views
Shared 3 years ago
23 views
Shared 3 years ago
5 views
Shared 3 years ago
6 views
Shared 3 years ago
14 views